approval
saveVABYSMO (FARICIMAB-SVOA) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INTRAVITREAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 4
same company · ±60 days · 6
- approvalmosunetuzumab: LUNSUMIO (MOSUNETUZUMAB-AXGB) — FDA approvalDec 22, 2022
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalDec 21, 2022
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalDec 21, 2022
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalDec 9, 2022
- approvalEVRYSDI: EVRYSDI (RISDIPLAM) — FDA approvalMar 24, 2023
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalDec 2, 2022
comments(0)
5-min edit window · permanent after that